Cellectar Biosciences Full-Year 2013 Financial Results And Recent Highlights
Published: Mar 26, 2014
MADISON, Wis., March 25, 2014 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (OTCQX:CLRB), a clinical stage biopharmaceutical company developing innovative agents for the detection and treatment of cancer, is providing an overview of its development programs and financial results for the year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.